{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:38:57Z","timestamp":1778787537767,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clindermatol.2022.02.011","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T02:11:11Z","timestamp":1644891071000},"page":"383-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The potential role for phage therapy for genetic modification of cutaneous diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Harry","family":"Meister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanette","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2022.02.011_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijantimicag.2008.06.001","article-title":"80th anniversary of the discovery of penicillin an appreciation of Sir Alexander Fleming","volume":"32","author":"Geddes","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/myc.12599","article-title":"A re-appraisal of the conventional history of antibiosis and penicillin","volume":"60","author":"Arseculeratne","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ajcp\/16.2.63","article-title":"Penicillin resistance; of bacteria; strain variations in penicillin sensitivity among bacterial species encountered in war wounds and infections","volume":"16","author":"Fleming","year":"1946","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0004","unstructured":"Frieden T. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf. Accessed January 20, 2021."},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0005","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges, and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0006","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11274-014-1655-7","article-title":"Natural solution to antibiotic resistance: bacteriophages \u201cThe Living Drugs","volume":"30","author":"Jassim","year":"2014","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0039","article-title":"Antibiotic resistance in the wild: an eco-evolutionary perspective","volume":"372","author":"Hiltunen","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0008","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3389\/fmicb.2018.02928","article-title":"Bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens","volume":"9","author":"Peterson","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0009","series-title":"StatPearls [Internet]","article-title":"Bacteriophages","author":"Kasman","year":"2019"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage therapy\u2013history from Twort and d'Herelle through Soviet experience to current approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13555-018-0275-9","article-title":"Propionibacterium (cutibacterium) acnes bacteriophage therapy in acne: current evidence and future perspectives","volume":"9","author":"Castillo","year":"2019","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fmed.2017.00094","article-title":"Phage therapy in a 16-year-old boy with netherton syndrome","volume":"4","author":"Zhvania","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.clindermatol.2022.02.011_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/antibiotics11020169","article-title":"Novel Phage Lysin Abp013 against Acinetobacter baumannii","volume":"11","author":"Chu","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0014","doi-asserted-by":"crossref","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0015","unstructured":"https:\/\/www.niaid.nih.gov\/search\/cognitive?search=bacteriophage, accessed 3\/10\/22."},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0016","series-title":"New center aims to advance bacteriophage therapy","author":"Dall","year":"2018"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0017","unstructured":"LaFee S, Buschman H. With OK from FDA, UC San Diego researchers prepare to launch novel phage study. Available at: https:\/\/health.ucsd.edu\/news\/releases\/Pages\/2019-01-08-FDA-okays-uc-san-diego-to-launch-novel-phage-study.aspx. Accessed January 20, 2020."},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cid\/ciw200","article-title":"Beyond antibiotics: new therapeutic approaches for bacterial infections","volume":"63","author":"Hauser","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0019","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00284-021-02395-y","article-title":"Isolation and characterization of a novel phage SaGU1 that infects staphylococcus aureus clinical isolates from patients with atopic dermatitis","volume":"78","author":"Shimamori","year":"2021","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/v13010007","article-title":"Staphylococcal phage in combination with staphylococcus epidermidis as a potential treatment for staphylococcus aureus-associated atopic dermatitis and suppressor of phage-resistant mutants","volume":"13","author":"Shimamori","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0022","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage therapy: clinical trials and regulatory hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-81-322-1777-0_7","article-title":"Bacteriophages as potential treatment option for antibiotic resistant bacteria","volume":"807","author":"Bragg","year":"2014","journal-title":"Ad Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0024","doi-asserted-by":"crossref","first-page":"E688","DOI":"10.3390\/v10120688","article-title":"A wake-up call: we need phage therapy now","volume":"10","author":"Moelling","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0026","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4939-7604-1_11","article-title":"Phage therapy: various perspectives on how to improve the art","volume":"1734","author":"Abedon","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clindermatol.2022.02.011_bib0027","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm Res"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:16Z","timestamp":1760033956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X22000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0738081X22000268"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role for phage therapy for genetic modification of cutaneous diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}